Impaired antibody response in an AIDS patient compromised the accuracy of the test. The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing from a cumbersome process to a rapid ...
BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...
HIV self-testing in home setting only marks the presence of HIV-1/2 antibodies or the HIV-1 p24 antigen; it does not provide a diagnosis. The self-testing kit has an inbuilt control line, which makes ...
MADRID — Rapid tests for the detection of the human immunodeficiency virus (HIV) shorten the window period to 2 or 3 weeks, and self-tests are as reliable and accurate as those carried out by ...
RICHMOND, British Columbia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- HIV testing just became faster, easier, and more accessible. The U.S. Food and Drug Administration (FDA) has approved the INSTI ® HIV Self ...
A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the creation of a rapid point-of-care test for HIV infection competitive with ...
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately.
In its effort to ensure that the spread of the HIV virus is drastically reduced, the Federal Government has approved the inclusion of ”Wondfo HIV I and II rapid test kits for use in the country. ...
HALIFAX, NS / ACCESS Newswire / April 17, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) and Lovell® Government Services announced today that they have partnered to serve federal healthcare systems such as ...
A study finds promising results on a new HIV prevention drug that's injected just twice a year. In the meantime, here's everything to know about HIV testing. Jessica was a writer on the Wellness team, ...
PROVIDENCE, R.I. & HALIFAX, Nova Scotia--(BUSINESS WIRE)--Maternova, Inc., accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira Inc. (TSXV: MIR), a ...
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results